BBIO Competitors & Alternatives
Compare BridgeBio Pharma Inc with similar stocks in the same industry
Biotechnology
BBIO
Main Stock$69.24
Tradestie Score
64
Market Cap
$10.22B
Revenue Growth
0.7%
Analyst Upside
+47.7%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$54.28
|
$15.70B | 27.9 | 61 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$14.53
|
$15.22B | - | 50 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$233.23
|
$12.36B | 26.4 | 56 | Compare |
|
EXEL
Exelixis Inc
|
$51.48
|
$11.09B | 17.2 | 60 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$31.43
|
$10.76B | - | 60 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$63.39
|
$10.74B | - | 65 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$56.55
|
$10.53B | 39.3 | 59 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$76.77
|
$10.49B | - | 66 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$515.04
|
$10.01B | - | 60 | Compare |
|
TECH
Bio-Techne Corp.
|
$56.66
|
$9.33B | 82.8 | 55 | Compare |
More BBIO Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry